DT&CRO CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8,770 KRW | +8.94% |
|
+2.10% | -51.63% |
More news
| 1 day | +8.94% | ||
| 1 week | +2.10% | ||
| 1 month | +31.68% | ||
| 3 months | -13.43% | ||
| 6 months | +3.42% | ||
| Current year | -51.63% |
1 week
7 710.00
8 910.00
1 month
6 660.009 600.00
Current year
5 580.0024 400.00
1 year
3 415.0024 400.00
3 years
3 415.0024 400.00
5 years
3 415.0024 400.00
10 years
3 415.0024 400.00
| Managers | Title | Age | Since |
|---|---|---|---|
Chae-Kyu Park
CEO | Chief Executive Officer | 63 | 17-12-31 |
Su-Young Choi
PSD | President | 67 | 21-08-31 |
Hak-Jae Lee
BRD | Director/Board Member | 54 | 17-03-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Chae-Kyu Park
CEO | Chief Executive Officer | 63 | 17-12-31 |
Deok-Sung Sun
BRD | Director/Board Member | 55 | 18-01-31 |
Hak-Jae Lee
BRD | Director/Board Member | 54 | 17-03-31 |
DT&CRO Co Ltd is a Korea-based company principally engaged in the contract research business. The Company is engaged in the provision of non-clinical and clinical trial services in the fields of pharmaceuticals, medical devices, food, chemicals and cosmetics. The Company is also engaged in the provision of analysis, efficacy evaluation and other services.
Calendar
2024-08-11
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -51.63% | 80.73M | |
| -24.16% | 7.76B | |
| +68.65% | 4.33B | |
| +2.72% | 2.63B | |
| -2.98% | 2.64B | |
| -46.17% | 2.16B | |
| -15.27% | 1.75B | |
| -22.12% | 1.46B | |
| +13.62% | 1.17B | |
| -43.81% | 1.14B |
- Stock Market
- Equities
- A383930 Stock
